,
1 min read
The pharmaceutical products approval process in Malaysia can be complex, especially for overseas companies aiming to register and market their products. Governed by strict Malaysia pharmaceutical regulations, companies must ensure compliance at every stage. Below are five essential FAQs to help you navigate the process effectively.
Pharmaceutical Products Approval Process in Malaysia: Key FAQs
Q.1.) How can a foreign pharmaceutical manufacturer register and market its pharmaceutical products in Malaysia?
Foreign pharmaceutical manufacturers must appoint a local agent (Product Registration Holder), which is a company locally registered in Malaysia, to hold the registration certificate.
This local agent will be responsible for all matters related to product registration with the Drug Control Authority (DCA) before the products can be marketed in the country.
Q.2.) Do pharmaceutical products need to be registered before being marketed in Malaysia?
Yes, all pharmaceutical products must be registered under the pharmaceutical products approval process in Malaysia before entering the market.
Registration ensures that the product meets the safety, efficacy, and quality standards set by the Regulatory authority. The National Pharmaceutical Regulatory Agency (NPRA), acting as the secretariat to the facilitates this evaluation and registration process.
Q.3.) Are there specific guidelines for the advertising of medicines in Malaysia?
Yes, there are specific advertising regulations in Malaysia. Businesses must be registered with the Companies Commission of Malaysia, and only pharmaceutical products registered with the Drug Control Authority can be advertised and sold.
This is regulated by the Medicines (Advertisement & Sale) Act 1956 and Medicine Advertisement Board Regulation 1976.
Q.4.) What is the role of the National Pharmaceutical Regulatory Agency (NPRA) in Malaysia?
The National Pharmaceutical Regulatory Agency NPRA (serves as the secretariat for the DCA) plays a key role in ensuring the safety, effectiveness, and quality of pharmaceutical, traditional, and cosmetic products in Malaysia.
It also oversees the registration of pharmaceutical products and the licensing of importers, manufacturers, and wholesalers.
Q.5.) Is there a national medicines policy in Malaysia?
Yes, Malaysia has a National Medicines Policy. This policy ensures that only safe, effective, and quality medicines that meet approved standards are registered and allowed for sale and use in the country.
This policy supports sustainable healthcare while aligning with broader Malaysia pharmaceutical regulations.
Conclusion
Understanding the pharmaceutical products approval process in Malaysia is essential for companies planning to enter this regulated market. With strict compliance requirements, oversight from bodies like the NPRA, and evolving Malaysia pharmaceutical regulations, having the right Regulatory strategy is critical for success.
Contact Freyr today for expert guidance tailored to your Regulatory needs.
